Literature DB >> 34297670

Mindfulness in Borderline Personality Disorder: Decentering Mediates the Effectiveness.

Carlos Schmidt1, Joaquim Soler, Cristina Carmona I Farrés, Matilde Elices, Elisabet Domínguez-Clavé, Daniel Vega, Juan C Pascual.   

Abstract

BACKGROUND: Mindfulness skills training is a core component of dialectical behavior therapy (DBT) that has proven to be an effective stand-alone treatment for the general symptoms commonly present in patients with borderline personality disorder (BPD). The aim of the present study was to compare the effectiveness of mindfulness-based DBT skills training (DBT-M) to interpersonal effectiveness-based DBT skills training (DBT-IE) in reducing BPD symptoms. We also evaluated the specific mechanism of action of these therapies through two proposed mediators: decentering and emotion dysregulation.
METHOD: A total of 102 participants diagnosed with BPD were included in the study. Multivariate repeated-measures ANOVAs were performed followed by a multiple mediation analysis.
RESULTS: The analyses showed that DBT-M was more effective than DBT-IE in reducing BPD symptoms, although both interventions were effective in reducing emotion dysregulation. We identified a serial mediation model in which DBT-M reduced BPD symptoms by increasing decentering ability, which in turn reduced emotion dysregulation. This mediation effect showed that changes in decentering preceded improvements in emotion dysregulation.
CONCLUSIONS: These findings underscore the key role of decentering as a primary mechanism of action in DBT-M, suggesting that this skill is a main component for BPD treatment.

Entities:  

Year:  2021        PMID: 34297670     DOI: 10.7334/psicothema2020.437

Source DB:  PubMed          Journal:  Psicothema        ISSN: 0214-9915


  1 in total

1.  A Machine Learning Approach for Predicting Non-Suicidal Self-Injury in Young Adults.

Authors:  Pere Marti-Puig; Chiara Capra; Daniel Vega; Laia Llunas; Jordi Solé-Casals
Journal:  Sensors (Basel)       Date:  2022-06-24       Impact factor: 3.847

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.